Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 6/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | RELA | Q04206 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31280415 | 0.84 | MDM2 (0.43) | NFE2L2PTGS1ERN1CYP1A2CYP1A1 | |
| SCHEMBL17163861 | 0.84 | MDM2 (0.43) | NFE2L2PTGS1ERN1CYP1A2CYP1A1 | |
| SCHEMBL273404 | 0.80 | ERN1 (0.56) | NFE2L2ARERN1LMNAMAPK1 | |
| SCHEMBL29432755 | 0.80 | ERN1 (0.56) | NFE2L2ARERN1LMNAMAPK1 | |
| SCHEMBL16955823 | 0.80 | NFE2L2 (0.47) | NFE2L2ARPTGS1ERN1LMNA | |
| SCHEMBL16950428 | 0.79 | L3MBTL1 (0.45) | LMNARAB9ACYP1A2ALDH1A1CYP2C19 | |
| SCHEMBL339513 | 0.79 | ALDH1A1 (0.43) | ARLMNAHTTALDH1A1 | |
| SCHEMBL13925800 | 0.78 | HMGCR (0.57) | NFE2L2ARPTGS1MAPK1RELA | |
| SCHEMBL24716965 | 0.78 | NFE2L2 (0.49) | NFE2L2PTGS1ERN1CYP1A2CYP1A1 | |
| SCHEMBL1792533 | 0.78 | CYP1A1 (0.61) | NFE2L2RAB9ACYP1A2CYP1A1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4707264-A2 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | Verbio SE (DE) | 2026-03-11 | — | — | EP | disclosed |
| EP-4122924-B1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | VERBIO SE (DE) | 2025-11-19 | — | — | EP | disclosed |
| US-12065450-B2 | Compounds and the use thereof in metathesis reactions | VERBIO SE (DE) | 2024-08-20 | — | — | US | disclosed |
| EP-4122924-A2 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | Verbio Vereinigte BioEnergie AG (DE) | 2023-01-25 | — | — | EP | disclosed |
| US-20230013959-A1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | VERBIO SE (DE) | 2023-01-19 | — | — | US | disclosed |
| US-11414446-B1 | Compounds and the use thereof in metathesis reactions | VERBIO VEREINIGTE BIOENERGIE AG | 2022-08-16 | — | — | US | disclosed |
| EP-3129365-B1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | VERBIO VER BIOENERGIE AG (DE) | 2022-05-04 | — | — | EP | disclosed |
| CN-106471005-B | Compounds and their use in metathesis reactions | 沃比奥联合生物能源公司 | 2020-04-24 | — | — | CN | disclosed |
| US-20190119311-A1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | VERBIO VEREINIGTE BIOENERGIE AG (DE) | 2019-04-25 | — | — | US | disclosed |
| US-10106566-B2 | Compounds and the use thereof in metathesis reactions | XIMO AG (CH) | 2018-10-23 | — | — | US | disclosed |
| EP-3129365-A1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | XiMo AG (CH) | 2017-02-15 | — | — | EP | disclosed |
| US-20170037069-A1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | VERBIO SE (DE) | 2017-02-09 | — | — | US | disclosed |
| WO-2015155593-A1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | XIMO AG (CH) | 2015-10-15 | — | — | WO | disclosed |
| EP-2900645-A1 | 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION | Bayer CropScience AG (DE) | 2015-08-05 | — | — | EP | disclosed |
| WO-2010093535-A1 | GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE | MERCK SHARP & DOHME CORP. (US) | 2010-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190119311-A1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | PRMT6, CYP2D6, POR | NFE2L2 867/4885AR 606/4885PTGS1 1728/4885 |
| US-11414446-B1 | Compounds and the use thereof in metathesis reactions | PRMT6, CYP2D6, POR | NFE2L2 867/4885AR 606/4885PTGS1 1728/4885 |
| US-12065450-B2 | Compounds and the use thereof in metathesis reactions | PRMT6, CYP2D6, POR | NFE2L2 867/4885AR 606/4885PTGS1 1728/4885 |
| US-10106566-B2 | Compounds and the use thereof in metathesis reactions | CYP2D6, PRMT6, POR | NFE2L2 660/4885AR 662/4885PTGS1 1620/4885 |
| US-20230013959-A1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | PRMT6, CYP2D6, POR | NFE2L2 867/4885AR 606/4885PTGS1 1728/4885 |
| US-20170037069-A1 | COMPOUNDS AND THE USE THEREOF IN METATHESIS REACTIONS | CYP2D6, PRMT6, POR | NFE2L2 660/4885AR 662/4885PTGS1 1620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.